Anamika Bajpai

Pharmacology Lead | FDA-Approved Global Drug Development | BLA Submission & Clinical Communications | 14+ Publications | Invited Speaker & Panelist | Scientific Communications | Immunology

Role
Research Investigator-axatilimab (Anti-csf1r) at Incyte
Location
Philadelphia, PA, US
LinkedIn followers
500 followers

About Anamika Bajpai

I am a scientist‑founder and educator building V‑CAPE Mentorship (Vedanta – Centre for…

Experience

  1. Research Investigator-axatilimab (Anti-csf1r)

    Incyte

    Oct 2022 — Present · US

    As axatilimab-preclinical lead, I orchestrate the mechanism of action of axatilimab. This encompasses:*the study design,*protocol development,*coordination with CROs,*comprehensive data analysis,*Author and review regulatory documents; BLA, IB, USPI, CCDS, Drug label, IDP, preclinical reports, NDS, safety modules*working in highly collaborative cross-functional teams,*supporting the global program team*presenting the program updates to cross functional executive and senior management global teams and external stakeholders, advisory board *Mentored co-op, intern * Lead author and presenter at American society of hematology 2024 (Axatilimab in cGVHD- MoA) Through meticulous attention to detail and a proactive approach, I ensured the successful progression of the project that leads to 5 bravo awards for my sincere efforts

Education

  • Drexel University's LeBow College of Business

    Executive MBA

  • Temple University - Lewis Katz School of Medicine

    Post Doctoral Fellow

  • Sanjay Gandhi Postgraduate Institute of Medical Sciences

    Doctor of Philosophy - PhD

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anamika Bajpai — Research Investigator-axatilimab (Anti-csf1r) at Incyte in Philadelphia, PA, US | Unifers